
KEY PUBLICATIONS
Translational Materials Innovation Group

CARPA: “Next-Generation Measurement Assay for Nanomedicine”
Complement-activation related pseudoallergy (CARPA) is a potentially lethal acute immune toxicity caused by many intravenous drugs that contain nanoparticles or proteins. The integration of our group’s biomimetic membrane platform with state-of-the-art surface-based characterization tools has led to a promising new approach for real-time monitoring and better understanding of the complement activation process.